Merkel cell carcinoma can be indolent: A case with 7 locoregional recurrences over 15 years highlights the importance of patient-tailored management

by Alyssa Breneman, BA, Tomoko Akaike, MD, Kelly G. Paulson, MD, Debra L. Breneman, MD, Paul Nghiem, MD, PhD
Published 2021-10-01

Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients

by Song Y. Park, MD, Candice Church, PhD, Nora A. Alexander, BS, Michi M. Shinohara, MD, Kelly G. Paulson, MD, PhD, Karl D. Lewis, MD, Nancy S. Lee, MD, Paul Nghiem, MD, PhD
Published 2021-02-01

Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck

by Seesha R. Takagishi, BS, Tessa E. Marx, BS, Christopher Lewis, BS, Erica S. Tarabadkar, MD, Ilsa D. Juhlin, Astrid Blom, MD, Jayasri G. Iyer, MD, Jay J. Liao, MD, Yolanda D. Tseng, MD MPhil, Teresa Fu, MD, Paul Nghiem, MD PhD, Upendra Parvathaneni, MBBS FRANZCR
Published 2016-10-01